Migdal Insurance & Financial Holdings Ltd. Reduces Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Migdal Insurance & Financial Holdings Ltd. decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 57.5% during the fourth quarter, Holdings Channel reports. The fund owned 599,007 shares of the exchange traded fund’s stock after selling 810,193 shares during the period. SPDR S&P Biotech ETF comprises approximately 1.1% of Migdal Insurance & Financial Holdings Ltd.’s investment portfolio, making the stock its 24th biggest position. Migdal Insurance & Financial Holdings Ltd.’s holdings in SPDR S&P Biotech ETF were worth $53,485,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Roundview Capital LLC raised its stake in shares of SPDR S&P Biotech ETF by 275.4% in the first quarter. Roundview Capital LLC now owns 7,599 shares of the exchange traded fund’s stock worth $683,000 after buying an additional 5,575 shares during the period. U.S. Capital Wealth Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the 1st quarter valued at approximately $222,000. Synovus Financial Corp raised its stake in SPDR S&P Biotech ETF by 559.1% during the 1st quarter. Synovus Financial Corp now owns 15,462 shares of the exchange traded fund’s stock valued at $1,390,000 after purchasing an additional 13,116 shares during the period. Vontobel Holding Ltd. raised its stake in SPDR S&P Biotech ETF by 6.7% during the 1st quarter. Vontobel Holding Ltd. now owns 6,400 shares of the exchange traded fund’s stock valued at $575,000 after purchasing an additional 400 shares during the period. Finally, Sequoia Financial Advisors LLC raised its stake in SPDR S&P Biotech ETF by 17.6% during the 1st quarter. Sequoia Financial Advisors LLC now owns 2,234 shares of the exchange traded fund’s stock valued at $201,000 after purchasing an additional 334 shares during the period.

SPDR S&P Biotech ETF Trading Down 0.4 %

XBI traded down $0.33 on Wednesday, hitting $85.28. 8,042,365 shares of the company’s stock traded hands, compared to its average volume of 11,661,967. The company’s 50 day simple moving average is $93.86 and its 200-day simple moving average is $84.12. The firm has a market cap of $6.62 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.